Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3710370018 | Ibandronic acid-containing product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3710371019 | Product containing ibandronic acid in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ibandronic acid-containing product in oral dose form | Is a | Product manufactured as oral dose form (product) | true | Inferred relationship | Some | ||
| Ibandronic acid-containing product in oral dose form | Has active ingredient | Ibandronic acid (substance) | true | Inferred relationship | Some | 1 | |
| Ibandronic acid-containing product in oral dose form | Is a | Product containing ibandronic acid (medicinal product) | true | Inferred relationship | Some | ||
| Ibandronic acid-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely ibandronic acid 50 milligram/1 each conventional release oral tablet | Is a | False | Ibandronic acid-containing product in oral dose form | Inferred relationship | Some | |
| Ibandronate sodium 2.5 mg oral tablet | Is a | False | Ibandronic acid-containing product in oral dose form | Inferred relationship | Some | |
| Product containing precisely ibandronate sodium 150 milligram/1 each conventional release oral tablet | Is a | False | Ibandronic acid-containing product in oral dose form | Inferred relationship | Some | |
| Product containing only ibandronic acid in oral dose form (medicinal product form) | Is a | True | Ibandronic acid-containing product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR